These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6351100)

  • 21. [Case of intention myoclonus (Lance-Adams syndrome) and a dramatic effect of L-5-hydroxytryptophan].
    Satoyoshi E; Kinoshita M; Takazawa Y; Yoda K
    Rinsho Shinkeigaku; 1976 Sep; 16(9):654-60. PubMed ID: 1087598
    [No Abstract]   [Full Text] [Related]  

  • 22. Palatal myoclonus treated with 5-hydroxytryptophan and a decarboxylase-inhibitor.
    Magnussen I; Dupont E; Prange-Hansen A; de Fine Olivarius B
    Acta Neurol Scand; 1977 Mar; 55(3):251-53. PubMed ID: 300537
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of L-5HTP with and without carbidopa on plasma beta-endorphin and pain perception. Possible implications in migraine prophylaxis.
    Genazzani AR; Sandrini G; Facchinetti F; Rizzo V; Alfonsi E; Sances G; Calvani M; Nappi G
    Cephalalgia; 1986 Dec; 6(4):241-5. PubMed ID: 2948652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: Treatment of post-anoxic intention myoclonus.
    Van Woert MH; Sethy VH
    Lancet; 1974 Jun; 1(7869):1285. PubMed ID: 4134164
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
    Chadwick D; Hallett M; Harris R; Jenner P; Reynolds EH; Marsden CD
    Brain; 1977 Sep; 100(3):455-87. PubMed ID: 412560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New therapeutic possibilities in depression: 5-hydroxytryptophan].
    López-Ibor Aliño JJ; Ayuso Gutiérrez JL; Montejo Iglesias ML
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1975; 3(3):151-62. PubMed ID: 1099879
    [No Abstract]   [Full Text] [Related]  

  • 27. Beneficial effects of serotonin precursors in postanoxic action myoclonus.
    De Léan J; Richardson JC; Hornykiewicz O
    Neurology; 1976 Sep; 26(9):863-8. PubMed ID: 1084968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manipulation of brain serotonin in the treatment of myoclonus.
    Chadwick D; Jenner P; Harris R; Reynolds EH; Marsden CD
    Lancet; 1975 Sep; 2(7932):434-5. PubMed ID: 51240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From the NIH: New treatment for myoclonus patients.
    JAMA; 1980 May; 243(17):1705-6. PubMed ID: 6965990
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan.
    Gascon G; Wallenberg B; Daif AK; Ozand P
    Ann Neurol; 1988 Sep; 24(3):453-5. PubMed ID: 3265864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myoclonus.
    Marsden CD
    Mod Trends Neurol; 1975; 6():321-2. PubMed ID: 1105145
    [No Abstract]   [Full Text] [Related]  

  • 32. Functional independence in post-anoxic myoclonus: contribution of L-5-HTP sodium valproate and clonazepam.
    Carroll WM; Walsh PJ
    Br Med J; 1978 Dec; 2(6152):1612. PubMed ID: 365292
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter: L 5-Hydroxytryptophan and mood.
    Trimble M; Chadwick D; Reynolds EH; Marsden CD
    Lancet; 1975 Mar; 1(7906):583. PubMed ID: 47066
    [No Abstract]   [Full Text] [Related]  

  • 34. 5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects.
    Byerley WF; Judd LL; Reimherr FW; Grosser BI
    J Clin Psychopharmacol; 1987 Jun; 7(3):127-37. PubMed ID: 3298325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Indications for L-5-hydroxytryptophan in neurology].
    Uldry PA; Regli F
    Rev Med Suisse Romande; 1987 Sep; 107(9):703-7. PubMed ID: 2962265
    [No Abstract]   [Full Text] [Related]  

  • 36. Myoclonus, ataxia, and hypoventilation: response to L-5-hydroxytryptophan.
    Feit H; Kirkpatrick J; Van Woert MH; Pandian G
    Neurology; 1983 Jan; 33(1):109-12. PubMed ID: 6600288
    [No Abstract]   [Full Text] [Related]  

  • 37. L-5HTP in depression resistant to re-uptake inhibitors. An open comparative study with tranylcypromine.
    Nolen WA; van de Putte JJ; Dijken WA; Kamp JS
    Br J Psychiatry; 1985 Jul; 147():16-22. PubMed ID: 3933601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A deficiency of dihydrobiopterin synthesis. The effects of L-dopa, 5HTP and BH4].
    Fujita N; Tanaka K; Nakajima T; Miyatake T; Ohwada M
    Rinsho Shinkeigaku; 1988 Apr; 28(4):376-81. PubMed ID: 3265083
    [No Abstract]   [Full Text] [Related]  

  • 39. [Utilization of levo-5-hydroxytryptophan in post-anoxic myoclonus].
    Rascol A; Guiraud-Chaumeil B; Laboucarie J; Montastruc JL; El-Hage W
    Therapie; 1978; 33(5):623-8. PubMed ID: 311085
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of L-5HTP and drugs acting on serotonin metabolism in various myoclonic syndromes.
    Avanzini G; Bossi L; Caraceni T; Consolazione A; Franceschetti S; Negri S; Parati E
    Monogr Neural Sci; 1980; 5():142-52. PubMed ID: 6976509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.